American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$544M |
| 2 |
Apple
AAPL
|
+$224M |
| 3 |
Exxon Mobil
XOM
|
+$219M |
| 4 |
Meta Platforms (Facebook)
META
|
+$189M |
| 5 |
CRH
CRH
|
+$177M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$402M |
| 2 |
Colgate-Palmolive
CL
|
+$255M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$235M |
| 4 |
Starbucks
SBUX
|
+$175M |
| 5 |
Equinix
EQIX
|
+$168M |
Sector Composition
| 1 | Technology | 27.37% |
| 2 | Financials | 12.82% |
| 3 | Healthcare | 11.58% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2551
The Honest Company
HNST
$447M
| $325K | ﹤0.01% |
111,141
+32,586
| +41% | +$95.2K |
|
2552
Select Medical
SEM
$1.55B
| $324K | ﹤0.01% |
+17,164
| New | +$324K |
|
2553
Kymera Therapeutics
KYMR
$3.36B
| $324K | ﹤0.01% |
10,847
-36,820
| -77% | -$1.1M |
|
2554
Blackbaud
BLKB
$3.38B
| $323K | ﹤0.01% |
4,245
-603
| -12% | -$45.9K |
|
2555
Silgan Holdings
SLGN
$4.71B
| $323K | ﹤0.01% |
7,626
+36
| +0.5% | +$1.52K |
|
2556
Jasper Therapeutics
JSPR
$39.5M
| $322K | ﹤0.01% |
14,204
+3,032
| +27% | +$68.8K |
|
2557
Brown-Forman Class A
BF.A
$13.2B
| $322K | ﹤0.01% |
7,299
+289
| +4% | +$12.8K |
|
2558
Telos
TLS
$490M
| $322K | ﹤0.01% |
79,988
+8,229
| +11% | +$33.1K |
|
2559
Ribbon Communications
RBBN
$676M
| $321K | ﹤0.01% |
97,718
+1,962
| +2% | +$6.46K |
|
2560
Arcos Dorados Holdings
ARCO
$1.43B
| $320K | ﹤0.01% |
35,567
-92,824
| -72% | -$835K |
|
2561
PepGen
PEPG
$48.5M
| $320K | ﹤0.01% |
20,028
+3,326
| +20% | +$53.1K |
|
|
FLG
2562
Flagstar Financial, Inc.
FLG
$5.27B
| $319K | ﹤0.01% |
+33,023
| New | +$319K |
|
2563
Vivid Seats
SEAT
$110M
| $318K | ﹤0.01% |
2,762
+518
| +23% | +$59.6K |
|
2564
Tenaya Therapeutics
TNYA
$196M
| $317K | ﹤0.01% |
102,114
+22,146
| +28% | +$68.7K |
|
2565
Inogen
INGN
$231M
| $314K | ﹤0.01% |
38,627
+9,626
| +33% | +$78.3K |
|
2566
Codexis
CDXS
$219M
| $312K | ﹤0.01% |
100,734
+16,019
| +19% | +$49.7K |
|
2567
Rush Street Interactive
RSI
$2.02B
| $311K | ﹤0.01% |
+32,406
| New | +$311K |
|
2568
CAVA Group
CAVA
$7.38B
| $309K | ﹤0.01% |
+3,335
| New | +$309K |
|
2569
COPT Defense Properties
CDP
$3.46B
| $309K | ﹤0.01% |
12,344
| – | – |
|
|
TSVT
2570
DELISTED
2seventy bio
TSVT
| $308K | ﹤0.01% |
79,953
+11,363
| +17% | +$43.7K |
|
2571
Erasca
ERAS
$443M
| $308K | ﹤0.01% |
130,407
+47,917
| +58% | +$113K |
|
2572
Tactile Systems Technology
TCMD
$301M
| $307K | ﹤0.01% |
25,711
+9,608
| +60% | +$115K |
|
2573
Rush Enterprises Class B
RUSHB
$4.5B
| $307K | ﹤0.01% |
7,815
-136
| -2% | -$5.34K |
|
|
ENFN
2574
DELISTED
Enfusion, Inc.
ENFN
| $306K | ﹤0.01% |
35,897
+5,253
| +17% | +$44.8K |
|
2575
Hillenbrand
HI
$1.73B
| $306K | ﹤0.01% |
7,641
-1,531
| -17% | -$61.3K |
|